Fifteen years in healthcare, from every side of the table.

Fifteen years in healthcare as an investor, a founder, and an executive inside a health system.

At J.P. Morgan Asset Management, I trained as an institutional investor.

Before healthcare, I managed a $1B reinvestment sleeve on the investment committee of a family office, leading diligence across roughly 100 external funds.

As a partner at Blueprint Health, I ran four accelerator cohorts; the program's companies include Touch Surgery, RubiconMD, Artemis, and NexHealth. At Junto Health, which I founded and ran for seven years, I worked with the health systems, payers, and pharma companies that buy healthcare technology, and built a consortium of two dozen hospital venture arms that ran 58 deals together. Along the way I built a national US market-entry accelerator for the Government of Canada and led a multi-year commercial strategy engagement with Novo Nordisk.

At Atlantic Health, I designed and led the venture studio, built to the growth strategy the CEO and Board set, and led every deal. The studio did three things at once: it backed the technologies reshaping care (Rad AI, Conceivable Life Sciences, FlyteHealth, Hyro), built new innovation capabilities across the system, and stood up new lines of business. Three of the funds named me to their LP advisory committee, and I still advise SpringTide Ventures.